Peter Joosten

A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma

Henk M. Lokhorst, Bronno van der Holt, Sonja Zweegman et al. · Blood · 2009 · 275 citations · Full text

Complete Remission of Accelerated Phase Chronic Myeloid Leukemia by Treatment With Leukemia-Reactive Cytotoxic T Lymphocytes

J.H. Frederik Falkenburg, Amon R. Wafelman, Peter Joosten et al. · Blood · 1999 · 269 citations

Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma

H M Lokhorst, Ingo GH Schmidt-Wolf, Pieter Sonneveld et al. · Haematologica · 2007 · 142 citations · Full text

Comorbidity is an independent prognostic factor in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP: a population-based cohort study

André Wieringa, Karin Boslooper, Mels Hoogendoorn et al. · British Journal of Haematology · 2014 · 78 citations

Immunodeficiencies, Prognosis, Pathology +19

Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study

Kim Holtzer-Goor, Martyn Ronald Schaafsma, Peter Joosten et al. · Quality of Life Research · 2015 · 52 citations · Full text